| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: APPX |
| Security Type |
Common Stock |
| Lead Underwriter |
CIBC World Markets Inc |
| Days In Registration |
71 |
| Date Filed |
3-Oct-2001 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Manufacture and wholesale injectable pharmaceuticals with a focus on oncology and anti-infective therapeutic areas |
| Revenue |
$192.0M |
| Net Income |
$12.6M |
| Shares Outstanding (post-offering) |
48.07M |
| CEO |
Patrick Soon-Shiong, M.D. |
| Number of Employees |
869 |
|
| Original Filing Information |
| US |
| Shares Filed |
9.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
9.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
1350.0K |
| File Amount |
$130.5M |
| File Price Range |
$16.00 - $13.00 |
| File Mid Price |
$14.50 |
Current Filing Information
(Amended 13-Dec-2001) |
|
US |
|
Shares Filed |
9.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
9.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$130.5M |
| · % Change from Original |
0.0 |
| File Price Range |
$16.00 - $13.00 |
| File Mid Price |
$14.50 |
|
